Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Blood-brain barrier and foetal-onset hydrocephalus, with a view on potential novel treatments beyond managing CSF flow.

Guerra M, Blázquez JL, Rodríguez EM.

Fluids Barriers CNS. 2017 Jul 13;14(1):19. doi: 10.1186/s12987-017-0067-0. Review.

2.

RNAi-mediated inhibition of Lgr5 leads to decreased angiogenesis in gastric cancer.

Xi HQ, Zhang KC, Li JY, Cui JX, Gao YH, Wei B, Huang D, Chen L.

Oncotarget. 2017 May 9;8(19):31581-31591. doi: 10.18632/oncotarget.15770.

3.

The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival.

Thompson EM, Keir ST, Venkatraman T, Lascola C, Yeom KW, Nixon AB, Liu Y, Picard D, Remke M, Bigner DD, Ramaswamy V, Taylor MD.

Neuro Oncol. 2017 Sep 1;19(9):1217-1227. doi: 10.1093/neuonc/nox033.

PMID:
28379574
4.

Endothelial NO Synthase-Dependent S-Nitrosylation of β-Catenin Prevents Its Association with TCF4 and Inhibits Proliferation of Endothelial Cells Stimulated by Wnt3a.

Zhang Y, Chidiac R, Delisle C, Gratton JP.

Mol Cell Biol. 2017 May 31;37(12). pii: e00089-17. doi: 10.1128/MCB.00089-17. Print 2017 Jun 15.

5.

The restorative role of annexin A1 at the blood-brain barrier.

McArthur S, Loiola RA, Maggioli E, Errede M, Virgintino D, Solito E.

Fluids Barriers CNS. 2016 Sep 21;13(1):17. Review.

6.

The Potential Role of Kallistatin in the Development of Abdominal Aortic Aneurysm.

Li J, Krishna SM, Golledge J.

Int J Mol Sci. 2016 Aug 11;17(8). pii: E1312. doi: 10.3390/ijms17081312. Review.

7.

Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking.

Pandey PK, Sharma AK, Gupta U.

Tissue Barriers. 2015 Dec 15;4(1):e1129476. doi: 10.1080/21688370.2015.1129476. eCollection 2016 Jan-Mar. Review.

8.

Silencing of FRAT1 by siRNA inhibits the proliferation of SGC7901 human gastric adenocarcinoma cells.

Yu Q, Shang LU, Yu H, Yang Z, Xu D.

Biomed Rep. 2016 Feb;4(2):223-226. Epub 2016 Jan 11.

9.

In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles.

Arami H, Khandhar A, Liggitt D, Krishnan KM.

Chem Soc Rev. 2015 Dec 7;44(23):8576-607. doi: 10.1039/c5cs00541h. Epub 2015 Sep 21. Review.

10.

Single and Compound Knock-outs of MicroRNA (miRNA)-155 and Its Angiogenic Gene Target CCN1 in Mice Alter Vascular and Neovascular Growth in the Retina via Resident Microglia.

Yan L, Lee S, Lazzaro DR, Aranda J, Grant MB, Chaqour B.

J Biol Chem. 2015 Sep 18;290(38):23264-81. doi: 10.1074/jbc.M115.646950. Epub 2015 Aug 4.

11.

Overexpression of FRAT1 is associated with malignant phenotype and poor prognosis in human gliomas.

Guo G, Zhong CL, Liu Y, Mao XG, Zhang Z, Jin J, Liu J, Yang L, Mao JM, Guo YH, Zhao YL.

Dis Markers. 2015;2015:289750. doi: 10.1155/2015/289750. Epub 2015 Apr 2.

12.

Anatomy and physiology of the blood-brain barrier.

Serlin Y, Shelef I, Knyazer B, Friedman A.

Semin Cell Dev Biol. 2015 Feb;38:2-6. doi: 10.1016/j.semcdb.2015.01.002. Epub 2015 Feb 11. Review.

13.

The contribution of CXCL12-expressing radial glia cells to neuro-vascular patterning during human cerebral cortex development.

Errede M, Girolamo F, Rizzi M, Bertossi M, Roncali L, Virgintino D.

Front Neurosci. 2014 Oct 15;8:324. doi: 10.3389/fnins.2014.00324. eCollection 2014.

14.

Alzheimer's disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs.

Zolezzi JM, Bastías-Candia S, Santos MJ, Inestrosa NC.

Front Aging Neurosci. 2014 Jul 28;6:176. doi: 10.3389/fnagi.2014.00176. eCollection 2014. Review.

15.

The heparan sulfate proteoglycan agrin contributes to barrier properties of mouse brain endothelial cells by stabilizing adherens junctions.

Steiner E, Enzmann GU, Lyck R, Lin S, Rüegg MA, Kröger S, Engelhardt B.

Cell Tissue Res. 2014 Nov;358(2):465-79. doi: 10.1007/s00441-014-1969-7. Epub 2014 Aug 9.

16.

Edaravone protects against methylglyoxal-induced barrier damage in human brain endothelial cells.

Tóth AE, Walter FR, Bocsik A, Sántha P, Veszelka S, Nagy L, Puskás LG, Couraud PO, Takata F, Dohgu S, Kataoka Y, Deli MA.

PLoS One. 2014 Jul 17;9(7):e100152. doi: 10.1371/journal.pone.0100152. eCollection 2014.

17.

Interleukin-1β-induced Wnt5a enhances human corneal endothelial cell migration through regulation of Cdc42 and RhoA.

Lee JG, Heur M.

Mol Cell Biol. 2014 Sep 15;34(18):3535-45. doi: 10.1128/MCB.01572-13. Epub 2014 Jul 14.

18.

Can we safely target the WNT pathway?

Kahn M.

Nat Rev Drug Discov. 2014 Jul;13(7):513-32. doi: 10.1038/nrd4233. Review.

19.

Progranulin deficiency promotes post-ischemic blood-brain barrier disruption.

Jackman K, Kahles T, Lane D, Garcia-Bonilla L, Abe T, Capone C, Hochrainer K, Voss H, Zhou P, Ding A, Anrather J, Iadecola C.

J Neurosci. 2013 Dec 11;33(50):19579-89. doi: 10.1523/JNEUROSCI.4318-13.2013.

20.

Development, maintenance and disruption of the blood-brain barrier.

Obermeier B, Daneman R, Ransohoff RM.

Nat Med. 2013 Dec;19(12):1584-96. doi: 10.1038/nm.3407. Epub 2013 Dec 5. Review.

Supplemental Content

Support Center